Metronomics Global Health Initiative

The Metronomics Global Health Initiative

On the Web

Latest articles

Beta-blockers disrupt mitochondrial bioenergetics & increase radiotherapy efficacy independently of BAR in medulloblastoma
2 August
Revisiting metronomic vinorelbine with mathematical modelling:
22 July
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial
24 June
Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults
24 June
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
24 May

Latest news

  • program of the 6th metronomic available

    the program of the next metronomic meeting in Grand Rapids is available on the dedicated post on the website

  • Maintenance chemotherapy in children with ALL is indeed metronomic chemotherapy

    A manuscript by members of MGHI has just been accepted for publication in Oncotarget. This works shows that maintenance chemotherapy in children with acute lymphoblastic leukemia exerts metronomic-like anti-endothelial effect associated with an increase in Thrombospondine-1. Read more soon in our "publication" section.

  • new ambassador from Nepal

    We are very honnored to welcome Pr. Bishnu D. Paudel from the National Academy of Medical Sciences in Kathmandu, Nepal. Pr Paudel is a pionner in palliative care in Nepal. Read more about him in the People section.

  • First Ambassador from Greece

    We are delighted to welcome Pr Briasoulis from the University of Ioannina as our first ambassador from Greece. Read more about him the "people section"